A patient with classic biphasic pulmonary blastoma harboring CD74–ROS1 fusion responds to crizotinib
Sign Up to like & getrecommendations! Published in 2018 at "OncoTargets and therapy"
DOI: 10.2147/ott.s150001
Abstract: Pulmonary blastoma (PB) is a rare aggressive lung malignancy with a poor prognosis. Surgical resection is the treatment of choice for localized disease, and there are no standard treatment guidelines for metastatic PB. Due to… read more here.
Keywords: cd74 ros1; ros1; pulmonary blastoma; classic biphasic ... See more keywords